287 related articles for article (PubMed ID: 35367329)
1. Protective effects of the Bupi Yishen formula on renal fibrosis through PI3K/AKT signaling inhibition.
Liu B; Deng J; Jie X; Lu F; Liu X; Zhang D
J Ethnopharmacol; 2022 Jul; 293():115242. PubMed ID: 35367329
[TBL] [Abstract][Full Text] [Related]
2. Fufang Shenhua tablet inhibits renal fibrosis by inhibiting PI3K/AKT.
Li R; Shi C; Wei C; Wang C; Du H; Liu R; Wang X; Hong Q; Chen X
Phytomedicine; 2023 Jul; 116():154873. PubMed ID: 37257328
[TBL] [Abstract][Full Text] [Related]
3. Uncovering Bupi Yishen Formula Pharmacological Mechanisms Against Chronic Kidney Disease by Network Pharmacology and Experimental Validation.
Zhang D; Liu B; Jie X; Deng J; Lu Z; Lu F; Liu X
Front Pharmacol; 2021; 12():761572. PubMed ID: 34867380
[TBL] [Abstract][Full Text] [Related]
4. Bupi Yishen formula may prevent kidney fibrosis by modulating fatty acid metabolism in renal tubules.
Liu B; Jie X; Deng J; Zhang S; Lu F; Liu X; Zhang D
Phytomedicine; 2023 Jun; 114():154767. PubMed ID: 37001297
[TBL] [Abstract][Full Text] [Related]
5. Network pharmacology and experiments in vivo and in vitro reveal that the Jia-Wei-Bu-Shen-Yi-Qi formula (JWBSYQF) and its active ingredient baicalein ameliorate BLM-induced lung fibrosis in mice via PI3K/Akt signaling pathway.
Shi H; Deng L; Zhou Y; Yu H; Huang X; Chen M; Lei Y; Dong J
J Ethnopharmacol; 2023 Oct; 315():116691. PubMed ID: 37247682
[TBL] [Abstract][Full Text] [Related]
6. Bupi Yishen formula attenuates kidney injury in 5/6 nephrectomized rats via the tryptophan-kynurenic acid-aryl hydrocarbon receptor pathway.
Mo Y; Jie X; Wang L; Ji C; Gu Y; Lu Z; Liu X
BMC Complement Med Ther; 2021 Aug; 21(1):207. PubMed ID: 34376166
[TBL] [Abstract][Full Text] [Related]
7. Study on the mechanism of Shenkang injection in the treatment of chronic renal failure based on the strategy of "Network pharmacology-Molecular docking-Key target validation".
Zhou L; Wang X; Sun Z; Bao X; Xue L; Xu Z; Dong P; Xia J
PLoS One; 2023; 18(10):e0291621. PubMed ID: 37796994
[TBL] [Abstract][Full Text] [Related]
8. Effective-component compatibility of Bufei Yishen formula II inhibits mucus hypersecretion of chronic obstructive pulmonary disease rats by regulating EGFR/PI3K/mTOR signaling.
Li J; Ma J; Tian Y; Zhao P; Liu X; Dong H; Zheng W; Feng S; Zhang L; Wu M; Zhu L; Liu S; Zhao D
J Ethnopharmacol; 2020 Jul; 257():112796. PubMed ID: 32344236
[TBL] [Abstract][Full Text] [Related]
9. Identification of the active compounds and functional mechanisms of Jinshui Huanxian formula in pulmonary fibrosis by integrating serum pharmacochemistry with network pharmacology.
Shao D; Liu X; Wu J; Zhang A; Bai Y; Zhao P; Li J
Phytomedicine; 2022 Jul; 102():154177. PubMed ID: 35636171
[TBL] [Abstract][Full Text] [Related]
10. Integrated strategy of network pharmacology, molecular docking, HPLC-DAD and mice model for exploring active ingredients and pharmacological mechanisms of Penthorum chinense Pursh against alcoholic liver injury.
Jiang Y; Zhong M; Zhan H; Tao X; Zhang Y; Mao J; Geng Z; Gao B
J Ethnopharmacol; 2022 Nov; 298():115589. PubMed ID: 35926779
[TBL] [Abstract][Full Text] [Related]
11. Integration of network pharmacology and serum medicinal chemistry to investigate the pharmacological mechanisms of QiZhuYangGan Decoction in the treatment of hepatic fibrosis.
Deng JW; Yuan S; Shi LP; Chen X; Liu J; Chen ZW; Tan KY; Yang Q; Cao WF
J Ethnopharmacol; 2024 Apr; 323():117730. PubMed ID: 38190954
[TBL] [Abstract][Full Text] [Related]
12. Yangyinghuoxue decoction exerts a treatment effect on hepatic fibrosis by PI3K/AKT pathway in rat model: based on the network pharmacology and molecular docking.
Bai YM; Liang S; Zhou B
Aging (Albany NY); 2024 Feb; 16(4):3773-3789. PubMed ID: 38364259
[TBL] [Abstract][Full Text] [Related]
13. Qihuang Zhuyu formula alleviates coronary microthrombosis by inhibiting PI3K/Akt/αIIbβ3-mediated platelet activation.
Ding Y; Xiang Q; Zhu P; Fan M; Tong H; Wang M; Cheng S; Yu P; Shi H; Zhang H; Chen X
Phytomedicine; 2024 Mar; 125():155276. PubMed ID: 38295661
[TBL] [Abstract][Full Text] [Related]
14. Yishen-Qingli-Huoxue formula attenuates renal fibrosis by inhibiting indoxyl sulfate via AhR/snai1 signaling.
Chen C; Sun S; Zhao J; Wu Q; He W; Sun W
Phytomedicine; 2023 Jan; 108():154546. PubMed ID: 36410103
[TBL] [Abstract][Full Text] [Related]
15. Study on the Potential Mechanism of Tonifying Kidney and Removing Dampness Formula in the Treatment of Postmenopausal Dyslipidemia Based on Network Pharmacology, Molecular Docking and Experimental Evidence.
Li X; Chen H; Yang H; Liu J; Li Y; Dang Y; Wang J; Wang L; Li J; Nie G
Front Endocrinol (Lausanne); 2022; 13():918469. PubMed ID: 35872979
[TBL] [Abstract][Full Text] [Related]
16. Xiaoyaosan decoction alleviated rat liver fibrosis via the TGFβ/Smad and Akt/FoxO3 signaling pathways based on network pharmacology analysis.
Zhou Y; Wu R; Cai FF; Zhou WJ; Lu YY; Zhang H; Chen QL; Su SB
J Ethnopharmacol; 2021 Jan; 264():113021. PubMed ID: 32479885
[TBL] [Abstract][Full Text] [Related]
17. Kokusaginine attenuates renal fibrosis by inhibiting the PI3K/AKT signaling pathway.
Wang Y; Han Y; Shang K; Xiao J; Tao L; Peng Z; Liu S; Jiang Y
Biomed Pharmacother; 2024 Jun; 175():116695. PubMed ID: 38713950
[TBL] [Abstract][Full Text] [Related]
18. Gualou xiebai decoction ameliorates cardiorenal syndrome type II by regulation of PI3K/AKT/NF-κB signalling pathway.
Wang YY; Liu YY; Li J; Zhang YY; Ding YF; Peng YR
Phytomedicine; 2024 Jan; 123():155172. PubMed ID: 37976694
[TBL] [Abstract][Full Text] [Related]
19. Network pharmacology-based approach uncovers the pharmacodynamic components and mechanism of Fructus Tribuli for improving endothelial dysfunction in hypertension.
Wang SY; Sun XC; Lv XY; Li JN; Han B; Liu KL; Wang S; Sheng HG; Zhang C; Guo F; Cui YD
J Ethnopharmacol; 2023 Nov; 316():116749. PubMed ID: 37295575
[TBL] [Abstract][Full Text] [Related]
20. Hovenianin A Alleviates Hepatic Fibrosis by Inhibiting the PI3K/AKT Pathway in TGF-β1-Induced HSCs Based on Network Pharmacology and Transcriptomic Analysis.
Kuang X; Ma T; Cai W; Yang J; Sun B; Zhang X; Liu B; Wang S; Xu F
Chem Biodivers; 2023 Mar; 20(3):e202201110. PubMed ID: 36825591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
